Skip to content
Trial Agents

Katholieke Universiteit te Leuven

Katholieke Universiteit te Leuven is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

1distinct trials
1recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 1 of 1 trials · Latest update first

A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis

Sponsor Janssen - Cilag International

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Katholieke Universiteit te Leuven?

The 2026-10-09 snapshot links Katholieke Universiteit te Leuven to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Katholieke Universiteit te Leuven?

The most frequently recorded therapeutic areas are Gastroenterology, Immunology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Katholieke Universiteit te Leuven conducted?

The linked trials record locations in 13 countries, including Belgium, Bulgaria, Czechia, Germany, Spain. These are trial locations, not confirmed office locations or countries where Katholieke Universiteit te Leuven delivered services.

What can this page tell me about Katholieke Universiteit te Leuven's trial experience?

Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Katholieke Universiteit te Leuven. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Katholieke Universiteit te Leuven

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.